These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20970136)

  • 21. Plaque regression--a new target for antiatherosclerotic therapy.
    Karha J; Bhatt DL
    Am Heart J; 2005 Mar; 149(3):384-7. PubMed ID: 15864225
    [No Abstract]   [Full Text] [Related]  

  • 22. Detecting the vulnerable plaque in patients.
    Gonçalves I; den Ruijter H; Nahrendorf M; Pasterkamp G
    J Intern Med; 2015 Nov; 278(5):520-30. PubMed ID: 26306911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is clonal hematopoiesis a new risk factor for cardiovascular diseases?: Clinical and experimental evidences.
    Páramo Fernandez JA
    Med Clin (Barc); 2018 Sep; 151(5):207-209. PubMed ID: 29802011
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stabilization of vulnerable coronary plaque].
    Chibana H; Mitsutake Y; Itaya N; Ueno T
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():306-10. PubMed ID: 22724220
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeting the unstable plaque in acute coronary syndromes.
    Thompson PL; Nidorf SM; Eikelboom J
    Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis.
    Chandrasekar B; Alanbaei M
    Eur Heart J; 2020 Dec; 41(46):4448. PubMed ID: 33051667
    [No Abstract]   [Full Text] [Related]  

  • 28. Requiem for the 'vulnerable plaque'.
    Libby P; Pasterkamp G
    Eur Heart J; 2015 Nov; 36(43):2984-7. PubMed ID: 26206212
    [No Abstract]   [Full Text] [Related]  

  • 29. [Should we begin with statin therapy in acute coronary syndrome?].
    Reiner Z
    Acta Med Croatica; 2004; 58(2):147-50. PubMed ID: 15208802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studying coronary plaque regression with IVUS.
    Nicholls SJ; Sipahi I
    J Interv Cardiol; 2006 Aug; 19(4):345. PubMed ID: 16881983
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.
    Voûte MT; Winkel TA; Poldermans D
    Expert Opin Drug Saf; 2010 Sep; 9(5):793-800. PubMed ID: 20557267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of plaque haemorrhage and neovascularization of coronary artery.
    Kodama T; Narula N; Agozzino M; Arbustini E
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):620-7. PubMed ID: 22828775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual histology assessment of coronary atheroma influences treatment strategy in the young acute coronary syndrome patient.
    Ormerod J; Johnston T; Ramcharitar S
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24477714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subsequent silent plaque rupture of nonculprit lesion in a patient with acute myocardial infarction.
    Takaoka N; Tsujita K; Kaikita K; Tayama S; Hokimoto S; Sugiyama S; Ogawa H
    Int J Cardiol; 2012 Jun; 157(3):e60-2. PubMed ID: 22078993
    [No Abstract]   [Full Text] [Related]  

  • 36. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studying coronary plaque regression with IVUS: a critical review of recent studies.
    Carlier SG; Tanaka K
    J Interv Cardiol; 2006 Feb; 19(1):11-5. PubMed ID: 16483334
    [No Abstract]   [Full Text] [Related]  

  • 38. New morphological insights on coronary plaque rupture: bridging the gap from anatomy to clinical presentation?
    Alfonso F; Virmani R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):83-6. PubMed ID: 21251633
    [No Abstract]   [Full Text] [Related]  

  • 39. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 40. OCT for the identification of vulnerable plaque in acute coronary syndrome.
    Sinclair H; Bourantas C; Bagnall A; Mintz GS; Kunadian V
    JACC Cardiovasc Imaging; 2015 Feb; 8(2):198-209. PubMed ID: 25677892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.